Keywords: gtx, enters, global, sarm, accord, merck, co

GTx enters global SARM accord with Merck & Co; deal includes Ph II sarcopenia drug

Article | 12 November 2007

US drugmaker GTx and pharmaceutical major Merck & Co have signed an agreement establishing an R&D and global strategic collaboration ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in